Azelead works on therapeutic fields such as:
Oncology, infection, neurological disorders, toxicity, ecotoxicology and rare diseases.

Zebrascreen
Fast and accurate evaluation of the efficacy of a drug

Zebratox
An innovative methodology
Rapid and accurate assessment of the impact of a drug
on cell populations and on the development of the zebrafish embryo

Oncology
— ONCO-Platform
— Xenotransplantation models
— Metastasis model
— High content screening

Infection
— Infection models (P1 / P2 / P3)
(in collaboration with Cemipai)
— Real-time imaging
(immune and pathogenic cells)
— High content screening

Neurological Disorders
— Blood-brain barrier
— Microglia
— Behavioral analysis
— Neurotoxic

Toxicity
Acute toxicity
Nervous System Development
— Cardiac development
(in collaboration with Physiostyme)
— Hematopoiesis and vessel development
— Ototoxicity
(in collaboration with CILcare)

Ecotoxicology
FET OCDE 236
— Embryo survival
— Coagulation of fertilized eggs
— Failure to form somites
— Failure to detach the tail bud
— Heartbeat failure
— LC50

Rare diseases
— Edition
— Transgenesis
— Inactivation of genes
— Characterization